ELAV-like protein 1 or HuR (human antigen R) is a protein that in humans is encoded by the ELAVL1gene.[1][2]
The protein encoded by this gene is a member of the ELAVL protein family. This encoded protein contains 3 RNA-binding domains and binds cis-acting AU-rich elements. One of its best-known functions is to stabilize mRNAs in order to regulate gene expression.[3]
↑Ma WJ, Cheng S, Campbell C, Wright A, Furneaux H (Jun 1996). "Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein". J Biol Chem. 271 (14): 8144–8151. doi:10.1074/jbc.271.14.8144. PMID8626503.
↑Ma WJ, Furneaux H (Feb 1997). "Localization of the human HuR gene to chromosome 19p13.2". Hum Genet. 99 (1): 32–33. doi:10.1007/s004390050305. PMID9003489.
Nabors LB, Suswam E, Huang Y, Yang X, Johnson MJ, King PH (2003). "Tumor necrosis factor alpha induces angiogenic factor up-regulation in malignant glioma cells: a role for RNA stabilization and HuR". Cancer Res. 63 (14): 4181–7. PMID12874024.
Abdelmohsen K, Lal A, Kim HH, Gorospe M (2007). "Posttranscriptional orchestration of an anti-apoptotic program by HuR". Cell Cycle. 6 (11): 1288–92. doi:10.4161/cc.6.11.4299. PMID17534146.
Bonaldo MF, Lennon G, Soares MB (1997). "Normalization and subtraction: two approaches to facilitate gene discovery". Genome Res. 6 (9): 791–806. doi:10.1101/gr.6.9.791. PMID8889548.
Sakai K, Kitagawa Y, Hirose G (1999). "Analysis of the RNA recognition motifs of human neuronal ELAV-like proteins in binding to a cytokine mRNA". Biochem. Biophys. Res. Commun. 256 (2): 263–268. doi:10.1006/bbrc.1999.0282. PMID10079173.
Spångberg K, Wiklund L, Schwartz S (2000). "HuR, a protein implicated in oncogene and growth factor mRNA decay, binds to the 3' ends of hepatitis C virus RNA of both polarities". Virology. 274 (2): 378–390. doi:10.1006/viro.2000.0461. PMID10964780.
Gallouzi IE, Steitz JA (2001). "Delineation of mRNA export pathways by the use of cell-permeable peptides". Science. 294 (5548): 1895–1901. doi:10.1126/science.1064693. PMID11729309.
Goldberg-Cohen I, Furneauxb H, Levy AP (2002). "A 40-bp RNA element that mediates stabilization of vascular endothelial growth factor mRNA by HuR". J. Biol. Chem. 277 (16): 13635–13640. doi:10.1074/jbc.M108703200. PMID11834731.
Yeap BB, Voon DC, Vivian JP, et al. (2002). "Novel binding of HuR and poly(C)-binding protein to a conserved UC-rich motif within the 3'-untranslated region of the androgen receptor messenger RNA". J. Biol. Chem. 277 (30): 27183–27192. doi:10.1074/jbc.M202883200. PMID12011088.
Li H, Park S, Kilburn B, et al. (2003). "Lipopolysaccharide-induced methylation of HuR, an mRNA-stabilizing protein, by CARM1. Coactivator-associated arginine methyltransferase". J. Biol. Chem. 277 (47): 44623–44630. doi:10.1074/jbc.M206187200. PMID12237300.
Giles KM, Daly JM, Beveridge DJ, et al. (2003). "The 3'-untranslated region of p21WAF1 mRNA is a composite cis-acting sequence bound by RNA-binding proteins from breast cancer cells, including HuR and poly(C)-binding protein". J. Biol. Chem. 278 (5): 2937–2946. doi:10.1074/jbc.M208439200. PMID12431987.
Wang W, Yang X, López de Silanes I, et al. (2003). "Increased AMP:ATP ratio and AMP-activated protein kinase activity during cellular senescence linked to reduced HuR function". J. Biol. Chem. 278 (29): 27016–27023. doi:10.1074/jbc.M300318200. PMID12730239.